APA

Zanin-Zhorov A., Weiss J. M., Trzeciak A., Chen W., Zhang J., Nyuydzefe M. S., Arencibia C., Polimera S., Schueller O., Fuentes-Duculan J., Bonifacio K. M., Kunjravia N., Cueto I., Soung J., Fleischmann R. M., Kivitz A., Lebwohl M., Nunez M., Woodson J., Smith S. L., West R. F., Berger M., Krueger J. G., Ryan J. L. & Waksal S. D. (20170919). Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Zanin-Zhorov Alexandra, Weiss Jonathan M, Trzeciak Alissa, Chen Wei, Zhang Jingya, Nyuydzefe Melanie S, Arencibia Carmen, Polimera Seetharam, Schueller Olivier, Fuentes-Duculan Judilyn, Bonifacio Kathleen M, Kunjravia Norma, Cueto Inna, Soung Jennifer, Fleischmann Roy M, Kivitz Alan, Lebwohl Mark, Nunez Margarita, Woodson Johnnie, Smith Shondra L, West Robert F, Berger Mark, Krueger James G, Ryan John L and Waksal Samuel D. 20170919. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Zanin-Zhorov A., Weiss J. M., Trzeciak A., Chen W., Zhang J., Nyuydzefe M. S., Arencibia C., Polimera S., Schueller O., Fuentes-Duculan J., Bonifacio K. M., Kunjravia N., Cueto I., Soung J., Fleischmann R. M., Kivitz A., Lebwohl M., Nunez M., Woodson J., Smith S. L., West R. F., Berger M., Krueger J. G., Ryan J. L. and Waksal S. D. (20170919). Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Zanin-Zhorov Alexandra, Weiss Jonathan M, Trzeciak Alissa, Chen Wei, Zhang Jingya, Nyuydzefe Melanie S, Arencibia Carmen, Polimera Seetharam, Schueller Olivier, Fuentes-Duculan Judilyn, Bonifacio Kathleen M, Kunjravia Norma, Cueto Inna, Soung Jennifer, Fleischmann Roy M, Kivitz Alan, Lebwohl Mark, Nunez Margarita, Woodson Johnnie, Smith Shondra L, West Robert F, Berger Mark, Krueger James G, Ryan John L and Waksal Samuel D. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. : Journal of immunology (Baltimore, Md. : 1950). 20170919.